ModupeIdowuMD
Hematology • Houston, TXClotting Disorder, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias
Associate Professor, Division of Hematology, Dept of Internal Medicine, University of Texas Medical School, Houston
Dr. Idowu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6400 Fannin St
Ste 2900
Houston, TX 77030Phone+1 713-704-3961Fax+1 713-704-3150
Education & Training
University of FloridaFellowship, Hematology and Medical Oncology, 2008 - 2010
Texas Tech University Health Sciences Center at LubbockResidency, Internal Medicine, 2005 - 2008- Texas Tech University Health Sciences Center School of MedicineClass of 2005
Certifications & Licensure
TX State Medical License 2007 - 2025- American Board of Internal Medicine Hematology
Clinical Trials
- Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. Start of enrollment: 2014 Sep 11
- Treatment of Adult Patients With Hemoglobin SC Disease (SCYTHE) Start of enrollment: 2015 Oct 12
Publications & Presentations
PubMed
- 7 citationsEchocardiographic parameters to identify sickle cell patients with cardio-pathology.Simbo M Chiadika, Mary Lim-Fung, Fiorella Llanos-Chea, Astrid Serauto Canache, Wei Yang
Echocardiography. 2018-05-14 - 2 citationsMulticenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease.Santosh L Saraf, Robert Hagar, Modupe Idowu, Ifeyinwa Osunkwo, Kimberly Cruz
Blood Advances. 2024-08-27 - 3 citationsRisk and protective factors for severe COVID-19 infection in a cohort of patients with sickle cell disease.Jessi Cai, Amber Chen-Goodspeed, Modupe Idowu
Journal of Investigative Medicine. 2022-06-01
Press Mentions
Cures for Sickle Cell Disease Arrive After a Painful JourneyOctober 1st, 2024
High Risks and High Costs for Young BloodSeptember 3rd, 2019
UT Physicians Comprehensive Sickle Cell CenterJanuary 14th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
